INTRODUCTION
Diabetes mellitus (DM) is a metabolic syndrome which is characterized by a chronic hyperglycemic status generated due to deficiency in insulin, resistance to insulin effect or both [1, 2] . Recently, the International Diabetes Federation (IDF) 7th edition of the Diabetes Atlas specified that 415 million people worldwide are diabetics [3] . Globally, a high incidence of DM is expected to exist in the Middle East and North Africa [4] .
Medicinal herbs and alternative medicine are safer and more effective alternatives compared to oral DM therapy [5] . Balanites aegyptiaca is a widespread terrestrial tree. It is native to most of Africa, the Middle East, Southern Asia and Pakistan [6] . The biologically active constituents of Balanites aegyptiaca include saponins, tannins, flavonoids, cardiac glycosides, fatty acids and sterols [7] The purified fractions of Balanites aegyptiaca possess significant antioxidant, antiinflammatory, antimicrobial and cytotoxic potentials [8] . In Egyptian folk medicine, the Balanites aegyptiaca is utilized as an oral antidiabetic remedy [9] . Balanites aegyptiaca fruits showed significant hypoglycemic effects in streptozocine (STZ)-induced hyperglycemia in animals [10, 11] . Moreover, another study revealed a hypoglycemic nephroprotective effect of Balanites aegyptiaca fruit (flesh) in streptozocine-induced DM in rats [12] . Similarly, Baragob et al [13] revealed a hypoglycemic action of Balanites aegyptiaca kernel in alloxaninduced diabetic rats.
Currently, there are no research studies that investigated the antidiabetic, biochemical and the histological effects of the whole Balanites aegyptiaca fruit (flesh and kernel) in type 2 DM animal model. This study was carried out to investigate the antidiabetic, biochemical and histological effects of the whole Balanites aegyptiaca fruit (kernel, flesh and their combination) in STZ-induced type 2 DM in rats. In addition, it compared the antidiabetic, biochemical and histological effects of the whole Balanites aegyptiaca fruit (flesh and kernel) with that of either fruit flesh alone or fruit kernel alone.
EXPERIMENTAL Plant material
Fruits of Balanites aegyptiaca were obtained from a local market in Jeddah, Saudi Arabia. The plant was identified and authenticated by a taxonomist, Dr Abdalla Elfeel, Faculty of Meteorology, Environment and Arid Land Agriculture, King Abdulaziz University, Jeddah, Saudi Arabia.
Drugs and chemicals
STZ was purchased from Sigma, USA. Metformin (Glucophage, 500 mg tablet, Merck Santé, France) was purchased from Jeddah, Saudi Arabia. All other chemicals were of high analytical grade.
Experimental animals
Male Wister rats (180 -240 g) were obtained from The Mansour Scientific Foundation for Research and Development, Jeddah, Saudi Arabia. Rats were housed at 25 °C with 12-hour light/dark cycle and offered water and food. They acclimatized to the laboratory conditions for one week prior to the initiation of the experiment. Animals were handled according to the Ethical Guidelines of King Abdulaziz University, Saudi Arabia, and strict compliance with the guidelines of the International standard and Institutional Animal Care and Use committee (IACUC) [14] . The work protocol was approved by the Scientific Research Ethics Committee of King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia (approval no. 1-18-01-009-0173).
Preparation of methanol extracts of Balanites aegyptiaca fruit
The method of Al-Malki et al [11] was adopted with some modifications. Also the crude powder of Balanites aegyptiaca (either kernel, flesh or their mixture) was placed in a stoppered container with methanol and allowed to stand at room temperature for a period of at least 3 days until the soluble matter dissolved. The rotary evaporator was employed for the efficient and gentle removal of solvents from samples. Then the mixture was strained, the Marc (the damp solid material) was pressed, and the combined liquids were clarified by filtration or decantation after standing and boiled to evaporate the methanol and then freeze dry for complete evaporation.
Preparation of STZ solution
Immediately before use, STZ (45 mg/kg) [15] was dissolved in 10 mm sodium citrate buffer, pH 4.5, then a suitable volume of 0.25 M sodium chloride solution was added to adjust the isotonicity.
Determination of working dose of Balanites aegyptiaca fruit extracts
A preliminary study was conducted with different doses of Balanites aegyptiaca fruit (Kernel, Flesh or their mixture) and the most effective dose (650 mg/kg) was chosen.
Animal studies
Rats were divided into 9 groups ( = 10). Group I (control): rats in this group were intraperitoneal (i.p.) injected with citrate buffer (0.05 M, pH 4.5). [17] . Treatment of control and diabetic rats with methanol extract of Balanites aegyptiaca fruit kernel, flesh and their mixture were continued for 6 weeks.
Assessment of body weight
The body weight (BW) of each rat was determined separately at the beginning of the experiment, 3 weeks and 6 weeks thereafter. The percent (%) body weight gain (BWG) was calculated after 3 and 6 weeks of treatment using Eq 1.
Assessment of fasting blood glucose
Fasting blood glucose was estimated after one week of STZ injection, 3 weeks after and then at the end of the 6th week by taking blood samples from the tail vein using Free Style Freedom Lite, Abbott [18] .
Sample collection
At the end of the experimental period, the rats were euthanized using deep ether anaesthesia, pancreases were dissected out, washed with normal saline and preserved in 10 % buffered formalin solution until they were used for the histopathological study. Blood samples were collected from the orbital plexus of their veins, left to clot, and centrifuged at 3000 rpm for serum separations.
Assessment of fasting serum insulin
Enzyme-linked immunosorbent assay (ELISA) (Dynex) fully automated immunoassay was used to determine fasting serum insulin concentration in all experimental groups using rats ELISA kit of Thermo Scientific, USA. A monoclonal antibody specific for rat insulin was utilized. The primary antibody was biotin antibody and the assay Avidin D, Horseradish Peroxidase (Av-HRP) was used to bind the detection antibody, biotin with high affinity. Cytokine concentrations were calculated using a standard lyophilized recombinant rat insulin.
Assessment of histopathological changes
Formalin-fixed pancreases from all the groups were dehydrated in ascending grades of isopropyl alcohol and cleared in xylene. The slides were stained with Haematoxylin and Eosin (H & E) and examined microscopically for the number and status of β islets of Langerhans.
Statistical analysis
Data were expressed as mean ± standard error of the mean (SEM). Statistical analysis of data was performed using one-way analysis of variance (ANOVA) followed by Tukey's post-hoc test. The Significant level was set at p ≤ 0.05. The statistical analysis was performed using SPSS software for Windows, version 22, Armonk, NY. Figures are constructed using GraphPad Prism software, version 5.
RESULTS

Effect of Balanites aegyptiaca extracts on rat body weight
The results of this study demonstrated that, after 3 and 6 weeks, rats injected with STZ showed significant decrease in BW when compared to the control group (p ≤ 0.001) ( Figure 1 ).
After 3 weeks, rats in both STZ + kernel and STZ + metformin groups showed significant increase in BW in comparison to the STZ group (p ≤ 0.01). On the other hand, after 3 weeks, rats in both STZ + flesh and STZ + Mixture groups showed non-significant changes in BW in comparison to STZ group (Figure 1 ).
After 6 weeks, rats in the STZ + kernel, STZ + mixture, and STZ + metformin groups showed a significant increase in BW when compared to the STZ group (p ≤ 0.001, 0.05, and 0.001 respectively). On the other hand, after 6 weeks, rats in the STZ + flesh group showed nonsignificant change in BW when compared to STZ group (Figure 1 ). In addition, the data presented in Figure 2 illustrate that after 3 and 6 weeks, rats injected with STZ showed a significant decrease in BW gain in comparison to the control group (p ≤ 0.001).
After 3 weeks and 6 weeks, rats in the STZ + Kernel, STZ + Flesh, STZ + MiXture, and STZ + Metformin groups showed a significant increase in % BW when compared to the STZ group ( Figure 2 ). Table 1 shows that gavaged methanol extract of Balanites aegypiaca kernel, flesh and their mixture in normal rats resulted in non-significant change in body weight and % body weight gain at all-time points in comparison to the control group.
Effect of Balanites aegyptiaca kernel, flesh or mixture on fasting blood glucose After 1, 3 and 6 weeks, rats injected with STZ showed significant increase in fasting blood glucose (FBG) when compared to the control group (p ≤ 0.001) (Figure 3 ). 91.9 ± 3.0 18.9 ± 1.4
Results are expressed as mean ± SEM (n = 10). a indicates significant difference compared to the control group at p ≤ 0.05 Table 1 shows that i.g. administration of the methanolic extract of Balanites aegypiaca kernel, flesh and their mixture in normal rats resulted in a non-significant change in FBG at all-time points in comparison to the control group. Table 1 showed that i.g. administration of the methanolic extract of Balanites aegypiaca kernel and flesh in normal rats resulted in significant increase in FSI measured at 6 weeks when compared to the control group (p ≤ 0.01 and 0.05). Conversely, Table 1 showed that i.g. administration of the methanolic extract of Balanites aegypiaca mixture in normal rats resulted in a non-significant change in FSI measured at 6 weeks when compared to the control group.
Effect of Balanites aegyptiaca kernel, flesh or mixture on pancreatic tissue histopathology
In control rat pancreas, islets of Langerhans were frequently seen as a lightly stained areas among the deeply stained exocrine acini ( In the diabetic rat pancreas, islets were less frequently seen in reared sections. They were also potentially small ( 
DISCUSSION
Diabetes mellitus is a chronic disease that is associated with a group of metabolic disorders. The main symptom of DM is elevated blood sugar level commonly known as hyperglycemia. The underlying causes of DM constitute either deficiency in insulin secretion or resistance to insulin action or both [19] .
Studies have already reported that DM cannot be treated with traditional medicine alone, as it has not been able to adjust the level of glucose completely and has many side effects [20] . In this respect, research on medicinal plants has shown their importance in diabetes therapy, as toxicological studies have proven them to be the safest [20] .
This study aims at investigating the potential hypoglycemic effect of the methanolic extract of different parts of Balanites aegypiaca fruit, including kernel, flesh and their mixture in a model of STZ-induced DM in male rats.
Diabetes is characterized by weight loss. The results of this study showed that STZ injection in rats resulted in a marked reduction in body weight in rats. Administration of the methanolic extract of Balanites aegypiaca kernel, flesh and their mixture to the rats brought about an increased body weight gain relative to STZtreated rats. Similarly, supplementation of Balanites aegyptiaca kernel cake (10 and 20 %) for three weeks significantly increased the body weight determined in alloxan-induced DM in rats [21] .
The results of the present study showed a hypoglycemic effect of methanolic extract of Balanites aegypiaca kernel, flesh and their mixture as indicated by the reduction in the levels of fasting blood glucose when compared with STZ-treated rats. Comparison between kernels, flesh and their mixture showed no significant difference between the hypoglycemic effects of the three fractions as estimated by ANOVA test. The effect of the three fractions is comparable to that of the reference oral hypoglycemic agent, metformin.
Similar to this results, the aqueous extract of the mesocarp of fruits of Balanites aegypiaca was reported to have an antidiabetic effect in STZinduced DM in mice [22] . In addition, our results are in line with other data obtained by Qusti et al [12] which reported that administration of Balanites aegyptiaca fruit (cortex) extract in a dose of 600 mg/kg/day significantly decreased the blood glucose concentration. Al-Malki et al [11] reported that Balanites aegyptiaca fruit reduced the levels of fasting blood glucose in a model of streptozocine-induced DM in rats.
A previous study by Ghanem et al [23] presented data that support the blood glucose lowering effect of the herbal tea of Balanites aegyptiaca fruits in STZ-induced diabetes in the rats. Recently, Ezzat et al [24] recorded antidiabetic effect of the methanolic extract of the powdered pericarps of Balanites aegyptiaca fruit against STZ-induced diabetic rats. Similarly, supplementation of Balanites aegyptiaca kernel cake (10 and 20 %) for a period of three weeks significantly reduced blood glucose in alloxaninduced DM in rats [21] . In agreement with this study results Shafik et al. [25] noticed that Balanites aegyptiaca kernel extract lowered the blood glucose levels in alloxan-induced DM in rats.
As far as we know, this study is the first study that reported the hypoglycemic action of kernel and flesh mixture of Balanites aegyptiaca fruits in STZ-induced DM in rats.
To identify the hypoglycemic mechanism of the methanolic extract of Balanites aegypiaca, serum insulin concentrations were measured in all the treated groups and compared with the STZtreated group. The results of this study showed that Balanites aegypiaca kernel and mixture resulted in a significant increase in serum insulin compared to STZ group. In contrast, Balanites aegypiaca flesh resulted in a non-significant increase in serum insulin compared to STZ group. The most probable mechanism of the effect may be the preservation of β-cells in the pancreas as found in the histopathological study conducted in this work.
The result of this study showed that Balanites aegyptiaca had a regenerative effect on pancreatic β-cells. As the density of β-cells population and their size in the treated groups were increased by the kernel and mixture administration compared to the diabetic group. The current research aims to restore the efficiency of pancreatic β-cells and improve their ability to secrete insulin as a basic line in the treatment of diabetes [26] .
There are no research studies that reported the ability of various parts of Balanites aegyptiaca fruit increasing the secretion of insulin and protecting the pancreas against the defect in STZ-induced diabetes in rats. However, concerning Balanites aegyptiaca active constituents, Ghanem et al [23] reported that the hypoglycemic effect of Balanites aegyptiaca might be related to the presence of bioactive components such as flavonoids, saponin, carvacrol and/or cinnamyl alcohol. Both carvacrol and cinnamyl alcohol enhance pancreatic secretion of insulin from β-cells and glucose homeostasis.
In this study, the use of the plant extracts in the non-diabetic animals did not affect rat weights and blood glucose levels compared to the control rats. However, it was observed that the groups that took the kernel and flesh extracts showed increased serum insulin level compared to the control group and this was accompanied by increased β-cells population in the pancreas.
